CHPA Applauds the Selection of a New FDA Commissioner

Association urges speedy confirmation to ensure stable leadership at food and drug agency

Washington, D.C. (March 16, 2009)—Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the announcement that Margaret Hamburg, M.D., will be nominated commissioner of the U.S. Food and Drug Administration (FDA): 

“The over-the-counter medicine and nutritional supplement industries applaud President Obama in naming Dr. Hamburg to lead FDA. The agency has a critical public-health responsibility, regulating fully one-quarter of everything American consumers purchase, and needs stable and competent leadership to accomplish its mission.

"CHPA and its member companies look forward to working with Dr. Hamburg and her deputy, Joshua Sharfstein, M.D., to ensure consumers continue to have access to the safe and effective consumer healthcare products upon which they rely. CHPA also will continue to advocate for full funding for FDA as a member of the broad-based Alliance for a Stronger FDA. The agency has been chronically underfunded for many years and requires sufficient resources to fulfill its myriad responsibilities in ensuring the safety of the nation’s food and drug supply. Those responsibilities are increasing as new medicines are introduced, including medicines new to over-the-counter healthcare, and as import quality and safety grow in importance.”

Contacts: Virginia Cox and Mimi Pappas, 202.429.9260


CHPA is the 128-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.